Status:
COMPLETED
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
Lead Sponsor:
University of Aarhus
Conditions:
Vitamin D Deficiency
Primary Hyperparathyroidism
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.
Detailed Description
The study investigates effects and safety of six months of vitamin D supplementation before and after surgery in primary hyperparathyroidism. Effects are assessed as changes in calcium homeostasis, bo...
Eligibility Criteria
Inclusion
- P-Ca-ion \> 1,30 mmol/l
- P-PTH \> 5 pmol/l
- P-OH25-vitamin D \< 80 nmol/l
Exclusion
- P-creatinin \> 120 mumol/l
- usage of Etalpha, Mimpara
- Cancer
- Sarcoidosis
- malabsorption
- pancreatitis
- alcohol abuse
- pregnancy
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00674154
Start Date
May 1 2008
End Date
August 1 2013
Last Update
November 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osteoporoseklinikken, Aarhus University Hospital, THG
Aarhus C, Denmark, 8000